awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38204368-8D839851-3FAB-4AB7-894E-C49235D01873
Q38204368-8D839851-3FAB-4AB7-894E-C49235D01873
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38204368-8D839851-3FAB-4AB7-894E-C49235D01873
Benefit-risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir.
P2860
Q38204368-8D839851-3FAB-4AB7-894E-C49235D01873
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38204368-8D839851-3FAB-4AB7-894E-C49235D01873
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8947a0a35e204be44d11c22650229bb5d753ff18
P2860
Antiviral activity and resistance of HCV NS5A replication complex inhibitors.